2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$29.44+$0.01 (+0.03%)
Price as of Aug 21, 2026 7:18 PM EDT- $1.6BMarket Cap
- 118.16%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$29.44+$0.01 (+0.03%)
MAZE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.43 | ||
Change | +$0.50 (+1.73%) | ||
Open | $28.98 | ||
High | $29.84 | ||
Low | $28.98 | ||
Previous Close | $28.93 | ||
Volume | 280,585 | ||
30-Day Average Volume | 348,207 | ||
1-Week Change | 8.28% | ||
1-Month Change | 0.44% | ||
1-Year Change | 118.16% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.5M | ||
Total Assets | $531.6M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$44.7M | ||
Free Cash Flow | -$15.2M | ||
EBIT | -$43.8M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $397.5M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -39 | ||
PEG | 1 | ||
Price/Free Cash Flow | -108 | ||
Price/Operating Cash Flow | -109 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue